M. Gąsior, D. Pres; M. Gierlotka; M. Hawranek; G. Słonka; A. Lekston; P. Buszman; Z. Kalarus; M. Zembala; L. Poloński, The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the PL-ACS registry., in Kardiol Pol, vol. 70, n. 12, 2012, pp. 1215-24, PMID23264238.
D. Tok, O. Turak; F. Ozcan; A. Durak; K. Cağlı; N. Başar; A. Işleyen; I. Kadife; HL. Kısacık, [Primary percutaneous coronary intervention for acute myocardial infarction in elderly aged 75 years and over: in-hospital mortality and clinical outcome]., in Turk Kardiyol Dern Ars, vol. 40, n. 7, novembre 2012, pp. 565-73, PMID23363938.
M. Bahloul, M. Samet; A. Chaari; N. Ben Aljia; MN. Ben Mbarek; H. Chelly; H. Dammak; C. Ben Hamida; N. Rekik; H. Kallel; M. Bouaziz, [Use of catecholamines for shock. A continuous debate!]., in Tunis Med, vol. 90, n. 4, aprile 2012, pp. 291-9, PMID22535343.
R. Nathan Coxford, E. Lang; S. Dowling, Dopamine versus norepinephrine in the treatment of shock., in CJEM, vol. 13, n. 6, novembre 2011, pp. 395-7, PMID22436478.
S. Marouene, JM. Juliard; JL. Golmard; P. Aubry; G. Ducrocq; L. Feldman; PG. Steg; A. Vahanian, [Clinical characteristics, management and pronostic evolution of patients admitted within six hours of symptom onset with st-segment elevation acute myocardial infarction complicated by cardiogenic shock : twenty year monocentric experience]., in Tunis Med, vol. 90, n. 10, ottobre 2012, pp. 715-9, PMID23096512.